by admin | Apr 9, 2026 | News & Opinions
By Université de Genève – Science Daily – Scientists have created a programmable drug system that can zero in on cancer cells with unprecedented accuracy. Built from synthetic DNA, it only activates when it detects a precise combination of tumor markers,...
by admin | Apr 8, 2026 | News & Opinions
By Genetic Engineering & Biotechnology News – Modern medicine has achieved extraordinary success in treating acute disease. Yet when it comes to chronic degenerative conditions, the diseases that dominate healthcare spending and disability in aging...
by admin | Apr 7, 2026 | News & Opinions
by Anne Trafton | MIT News – The cells can survive in the body for at least three months, producing enough insulin to control blood sugar levels, research shows. Most diabetes patients must carefully monitor their blood sugar levels and inject insulin multiple...
by admin | Apr 6, 2026 | News & Opinions
by Alisha Willett, Purdue University – PHYS.ORG – In back-to-back studies published in Nature, researchers from Purdue University and Columbia University report a naturally evolved gene-editing system that can activate genes, offering an advantage over...
by admin | Apr 3, 2026 | News & Opinions
By Tiare Dunlap – UCLA Health – A team of researchers led by UCLA’s Dr. Daniel Geschwind has received a $13.9 million grant from the California Institute for Regenerative Medicine to use human stem cell-based models to uncover the molecular and cellular...
